Rapid detection of Pseudomonas aeruginosa in mouse feces by colorimetric loop-mediated isothermal amplification

被引:60
作者
Goto, Motoki [2 ]
Shimada, Kayo [3 ]
Sato, Ayako [1 ]
Takahashi, Eri [1 ]
Fukasawa, Takafumi [1 ]
Takahashi, Tomoki [1 ]
Ohka, Seii [2 ]
Taniguchi, Takahide [4 ]
Honda, Eiichi [4 ]
Nomoto, Akio [2 ]
Ogura, Atsuo [2 ,5 ]
Kirikae, Teruo [3 ]
Hanaki, Ken-Ichi [1 ]
机构
[1] Iwate Med Univ, Ctr Expt Anim Res, Morioka, Iwate 0208505, Japan
[2] Univ Tokyo, Grad Sch Med, Ctr Dis Biol & Integrat Med, Bunkyo Ku, Tokyo 1130033, Japan
[3] Int Med Ctr Japan, Res Inst, Dept Infect Dis, Shinjuku Ku, Tokyo 1628655, Japan
[4] Tokyo Univ Agr & Technol, Dept Vet Med, Fuchu, Tokyo 1838509, Japan
[5] RIKEN BioResource Ctr, Tsukuba, Ibaraki 3050074, Japan
关键词
Hydroxy naphthol blue; Loop-mediated isothermal amplification; OprL gene; Pseudomonas aeruginosa; CYSTIC-FIBROSIS PATIENTS; POLYMERASE-CHAIN-REACTION; CLINICAL-SAMPLES; PCR; MICE; IDENTIFICATION; INFECTION; VIRUS; RELIABILITY; BACTEREMIA;
D O I
10.1016/j.mimet.2010.03.008
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A colorimetric loop-mediated isothermal amplification (LAMP) assay with hydroxy naphthol blue was designed to amplify a region in the outer membrane lipoprotein (oprL) gene of Pseudomonas aeruginosa. The LAMP assay showed 100% specificity for the serogroup and other bacteria, and the sensitivity was 10-fold higher than that of the PCR assays. The LAMP assay could detect P. aeruginosa inoculated in mouse feces at 130 colony-forming units (CFU)/0.1 g feces (3.25 CFU/reaction). The assay was completed within 2 h from DNA extraction. In a field trial, the LAMP assay revealed that none of the 27 samples was obtained from 2 specific pathogen-free (SPF) mouse facilities that were monitoring infection with P. aeruginosa; 1 out of 12 samples from an SPF mouse facility that was not monitoring infection with P. aeruginosa and 2 out of 7 samples from a conventional mouse facility were positive for P. aeruginosa. In contrast, P. aeruginosa was not detected in any of the samples by a conventional culture assay. Thus, this colorimetric LAMP assay is a simple and rapid method for P. aeruginosa detection. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:247 / 252
页数:6
相关论文
共 35 条
[1]   Natural pathogens of laboratory mice, rats, and rabbits and their effects on research [J].
Baker, DG .
CLINICAL MICROBIOLOGY REVIEWS, 1998, 11 (02) :231-+
[2]   Multiresistant waterborne pathogens isolated from water reservoirs and cooling systems [J].
Blasco, M. D. ;
Esteve, C. ;
Alcaide, E. .
JOURNAL OF APPLIED MICROBIOLOGY, 2008, 105 (02) :469-475
[3]   Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic [J].
Cheng, K ;
Smyth, RL ;
Govan, JRW ;
Doherty, C ;
Winstanley, C ;
Denning, N ;
Heaf, DP ;
vanSaene, H ;
Hart, CA .
LANCET, 1996, 348 (9028) :639-642
[4]   Burn wound infections [J].
Church, D ;
Elsayed, S ;
Reid, O ;
Winston, B ;
Lindsay, R .
CLINICAL MICROBIOLOGY REVIEWS, 2006, 19 (02) :403-+
[5]   SIMPLE-MODEL FOR THE STUDY OF PSEUDOMONAS-AERUGINOSA INFECTIONS IN LEUKOPENIC MICE [J].
CRYZ, SJ ;
FURER, E ;
GERMANIER, R .
INFECTION AND IMMUNITY, 1983, 39 (03) :1067-1071
[6]   PCR identification of Pseudomonas aeruginosa and direct detection in clinical samples from cystic fibrosis patients [J].
Da Silva, LVF ;
Levi, JE ;
Bento, CNO ;
Ramos, SRTD ;
Rozov, T .
JOURNAL OF MEDICAL MICROBIOLOGY, 1999, 48 (04) :357-361
[7]   Direct detection and identification of Pseudomonas aeruginosa in clinical samples such as skin biopsy specimens and expectorations by multiplex PCR based on two outer membrane lipoprotein genes, oprI and oprL [J].
DeVos, D ;
Lim, A ;
Pirnay, JP ;
Struelens, M ;
Vandenvelde, C ;
Duinslaeger, L ;
Vanderkelen, A ;
Cornelis, P .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (06) :1295-1299
[8]   Isolation of Enterococcus durans and Pseudomonas aeruginosa in a scid mouse colony [J].
Dietrich, HM ;
Khaschabi, D ;
Albini, B .
LABORATORY ANIMALS, 1996, 30 (02) :102-107
[9]   Outcomes of bacteremia in patients with cancer and neutropenia: Observations from two decades of epidemiological and clinical trials [J].
Elting, LS ;
Rubenstein, EB ;
Rolston, KVI ;
Bodey, GP .
CLINICAL INFECTIOUS DISEASES, 1997, 25 (02) :247-259
[10]  
GAYDOS JM, 1975, P SOC EXP BIOL MED, V149, P908